138 related articles for article (PubMed ID: 30003741)
1. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
Zhou T; Liu S; Yang L; Ju Y; Li C
J BUON; 2018; 23(3):713-719. PubMed ID: 30003741
[TBL] [Abstract][Full Text] [Related]
2. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
[TBL] [Abstract][Full Text] [Related]
5. Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.
Zhou T; Li Y; Yang L; Tang T; Zhang L; Shi J
Biomed Res Int; 2017; 2017():2603685. PubMed ID: 28497041
[TBL] [Abstract][Full Text] [Related]
6. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
[TBL] [Abstract][Full Text] [Related]
7. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of Annexin A3 in the osteosarcoma cell lines HOS and U2OS.
Zeng X; Wang S; Gui P; Wu H; Li Z
Mol Med Rep; 2019 Sep; 20(3):2583-2590. PubMed ID: 31524248
[TBL] [Abstract][Full Text] [Related]
11. The regulatory role of Annexin 3 in a nude mouse bearing a subcutaneous xenograft of MDA-MB-231 human breast carcinoma.
Li J; Zhou T; Liu L; Ju YC; Chen YT; Tan ZR; Wang J
Pathol Res Pract; 2018 Oct; 214(10):1719-1725. PubMed ID: 30236487
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Analysis of mRNA Expression Profiling Identified Lung Cancer-Related Gene in Xuanwei, China.
Wu C; Song G; Xiong G; Lu L; Zhou X; Duan Y
Clin Lab; 2018 Sep; 64(9):1517-1526. PubMed ID: 30274024
[TBL] [Abstract][Full Text] [Related]
13. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
14. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z
Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757
[TBL] [Abstract][Full Text] [Related]
15. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
16. [Expression of SM22α and its relationship with lymph node metastasis in breast cancer].
MA ZF; CUI NP; SHI JH; WANG HY; SHI SH; WEN M; LI Z
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2545-8. PubMed ID: 21092460
[TBL] [Abstract][Full Text] [Related]
17. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
[TBL] [Abstract][Full Text] [Related]
18. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients.
Razmkhah M; Jaberipour M; Safaei A; Talei AR; Erfani N; Ghaderi A
Eur Cytokine Netw; 2012; 23(3):72-7. PubMed ID: 23078970
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]